Search

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...

Optegra launches new fellowship programme

Leading eye health care group, Optegra, is proud to announce the appointment of its first Fellow, Mr Fadi Alfaqawi, as it unveils its Cataract and Refractive Surgery Fellowship Programme.

SpaMedica extends its ophthalmic training programme, creating vital placements for NHS registrars

The UK’s largest provider of NHS cataract surgery is already supporting 60 aspiring surgeons, and has recently appointed three staff members to further develop its training provision.

Shared vision: Father and son navigate life with glaucoma together

Glaucoma UK is a charity dedicated to supporting people living with glaucoma across the UK. They’re getting ready for Glaucoma Awareness Week, an annual awareness raising campaign, which is running from 24–30 June.

Dumfries and Galloway teen thrives as volunteer after sight loss

At just 18, Finlay Anderson has already achieved so much. Preparing to embark on a new academic journey at the University of Edinburgh to study Law, Finlay’s path has been paved with dedication to advocacy and volunteerism, which he began navigating from a young age after losing his sight.

Dry eye disease treatments come to the fore at 100%

Guidance on setting up, or enhancing, a Dry Eye disease clinic within the practice will be freely available from OSA members exhibiting at 100% Optical: 1–3 March. The ability to diagnose and treat a major irritation for many is winning...

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...

Conference Report: Building on a successful 2024: A week of learning at the Kabgayi Eye Unit

2024 was an exceptional year for us at Kabgayi Eye Unit (KEU). We hosted Rwanda’s first-ever international ophthalmology conference, established the Kabgayi Learning and Simulation Centre (KLAS) – a dedicated wet lab and skills transfer centre, and launched our training...

ABDO awards presented at graduation and prize giving ceremony

The president of the Association of British Dispensing Opticians (ABDO), Kevin Gutsell, presented six special awards at the Association's recent graduation and prize giving ceremony held at Canterbury Cathedral. ABDO Life Membership was awarded to Fiona Anderson, SMC (Tech), BSc...

Study flags evidence gaps in AI eye imaging devices approved for patient care

Uneven evidence and poor data transparency revealed in review of AI as a medical device. A review of regulator-approved medical AI models in eye care has found that they vary widely in providing evidence for clinical performance and lacked transparency...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...